Literature DB >> 29995208

Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.

Viviane Machado Andrade1, Mario Stevenson2.   

Abstract

HIV-1 persists in cellular reservoirs that cannot be eliminated by antiretroviral therapy (ART). The major reservoir in infected individuals on effective ART is composed of resting memory CD4+ T cells that harbor proviral cDNA, and undergo a state of latency in which viral gene expression is minimal to absent. The CD4+ T cell reservoir has been extensively characterized. However, other HIV-1-permissive cells may contribute to HIV-1 persistence. Lentiviruses have a long recognized association with macrophages. However, the role, if any, played by macrophages in HIV-1 persistence is not well understood. Macrophages are resistant to cell death upon HIV-1 infection, and can survive for long periods of time, making them ideal host cells in which the virus might persist. Studying macrophages is challenging, as these cells reside in nearly all tissues. Moreover, detecting viral DNA or RNA in macrophages does not necessarily indicate that these cells will produce replication-competent viral particles. Currently, the gold standard assay to detect cellular reservoirs is the ex vivo quantitative viral outgrowth assay (QVOA), which requires a patient blood draw. However, macrophages reside deep within tissues that are inaccessible in living subjects, such as the central nervous system (CNS). Therefore, tools other than QVOA must be developed to identify cellular reservoirs that reside in the tissues. In this review, we will focus on the main aspects involved in HIV-1 persistence, including the molecular mechanisms of viral evasion, the main cell types responsible for harboring persistent HIV-1 and the tissue compartments that are likely to be reservoirs for HIV-1.

Entities:  

Keywords:  CNS; HIV-1 infection; Macrophages; Persistence; Reservoir

Year:  2018        PMID: 29995208      PMCID: PMC6927576          DOI: 10.1007/s11481-018-9795-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  89 in total

Review 1.  Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.

Authors:  James M McMahon; Julie E Myers; Ann E Kurth; Stephanie E Cohen; Sharon B Mannheimer; Janie Simmons; Enrique R Pouget; Nicole Trabold; Jessica E Haberer
Journal:  AIDS Patient Care STDS       Date:  2014-07-21       Impact factor: 5.078

2.  HIV-1 Nef disrupts antigen presentation early in the secretory pathway.

Authors:  Matthew R Kasper; Jeremiah F Roeth; Maya Williams; Tracey M Filzen; Rebekah I Fleis; Kathleen L Collins
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

3.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

4.  Human Kupffer cells infected with HIV-1 in vivo.

Authors:  F T Hufert; J Schmitz; M Schreiber; H Schmitz; P Rácz; D D von Laer
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-07

5.  HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanisms.

Authors:  Manmeet K Mamik; Sugato Banerjee; Timothy F Walseth; Renee Hirte; Lin Tang; Kathleen Borgmann; Anuja Ghorpade
Journal:  J Neuroinflammation       Date:  2011-10-25       Impact factor: 8.322

6.  HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.

Authors:  Nawal Ben Haij; Rémi Planès; Kaoutar Leghmari; Manutea Serrero; Pierre Delobel; Jacques Izopet; Lbachir BenMohamed; Elmostafa Bahraoui
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

7.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

8.  Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses.

Authors:  Gina M Lenzi; Robert A Domaoal; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

9.  Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.

Authors:  Christian Wächter; Lee E Eiden; Nedye Naumann; Candan Depboylu; Eberhard Weihe
Journal:  J Neuroinflammation       Date:  2016-10-14       Impact factor: 8.322

10.  Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.

Authors:  Claudia R Avalos; Celina M Abreu; Suzanne E Queen; Ming Li; Sarah Price; Erin N Shirk; Elizabeth L Engle; Ellen Forsyth; Brandon T Bullock; Feilim Mac Gabhann; Stephen W Wietgrefe; Ashley T Haase; M Christine Zink; Joseph L Mankowski; Janice E Clements; Lucio Gama
Journal:  mBio       Date:  2017-08-15       Impact factor: 7.867

View more
  10 in total

1.  Editor's Commentary for Special Issue: "The Role of Macrophages in HIV Persistence".

Authors:  Tricia H Burdo
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-09       Impact factor: 4.147

2.  Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.

Authors:  Rebecca J Peters; Mario Stevenson
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

3.  Isolation, Transfection, and Culture of Primary Human Monocytes.

Authors:  Karlie Plaisance-Bonstaff; Celeste Faia; Dorota Wyczechowska; Duane Jeansonne; Cecilia Vittori; Francesca Peruzzi
Journal:  J Vis Exp       Date:  2019-12-16       Impact factor: 1.355

Review 4.  HIV transmitting mononuclear phagocytes; integrating the old and new.

Authors:  Erica E Vine; Jake W Rhodes; Freja A Warner van Dijk; Scott N Byrne; Kirstie M Bertram; Anthony L Cunningham; Andrew N Harman
Journal:  Mucosal Immunol       Date:  2022-02-16       Impact factor: 8.701

Review 5.  Monocytes and Macrophages as Viral Targets and Reservoirs.

Authors:  Ekaterina Nikitina; Irina Larionova; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

Review 6.  Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events.

Authors:  Kirstie Melissa Bertram; Orion Tong; Caroline Royle; Stuart Grant Turville; Najla Nasr; Anthony Lawrence Cunningham; Andrew Nicholas Harman
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

7.  Infectious Virus Persists in CD4+ T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Celina M Abreu; Rebecca T Veenhuis; Claudia R Avalos; Shelby Graham; Suzanne E Queen; Erin N Shirk; Brandon T Bullock; Ming Li; Kelly A Metcalf Pate; Sarah E Beck; Lisa M Mangus; Joseph L Mankowski; Janice E Clements; Lucio Gama
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

8.  The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages.

Authors:  Javan K Kisaka; Lee Ratner; George B Kyei
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

9.  Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation.

Authors:  Reema Patel; Maura M Manion; Elizabeth Laidlaw; Paul Wakim; Zeping Wang; Megan Anderson; Frances Galindo; Adam Rupert; Andrea Lisco; Theo Heller; Irini Sereti; Dima A Hammoud
Journal:  AIDS       Date:  2022-08-03       Impact factor: 4.632

Review 10.  HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.

Authors:  Shilpa Sonti; Adhikarimayum Lakhikumar Sharma; Mudit Tyagi
Journal:  Virus Res       Date:  2021-07-24       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.